LBG’s Janetta Brewer, Esq. and Gretchen Stup will join experts from key organizations across government, military, and academia at the 11th Annual Joint Civil & DoD CBRN Symposium. LBG is also an …
LBG’s Joe Rininger, Ph.D. will join “the brightest minds in bioprocessing” at BPI West on February 27 – March 2 in San Diego. Dr. Rininger, who is speaking and participating …
LBG has been recognized for its role in an innovative program in a press release titled “DARPA Team Begins Work on Field Deployable Whole Blood Equivalent.” Recently issued by DARPA, …
There is still time to register for the M-Corps Showcase Webinar: Case Study: MTEC Commercialization Grant Enabling Transformative Market Research and Financial Models on February 8 from 1 – 2 p.m. …
Article published in Genetic Engineering & Biotechnology News (GEN) LBG’s Georgia Sloboda and Patrick Falvey were asked to share their insights on the CDMO selection process with author Vivienne Raper …
The CDMO outsourcing market will experience a period of growth due to the expansion of the pharmaceutical sector. So selecting a CDMO that is a good fit is critical. …
LBG’s Frank Orlowski will have the opportunity to engage with companies presenting cutting-edge technologies and the latest breakthroughs in the biopharma industry on January 9 – 11 in San Francisco. …
LBG’s Marco Daoura, Principal Consultant, participated in M2D2 IMPACT Cycle 4, advising a minimally invasive vessel occluding surgical device. IMPACT is a 12-week accelerator program that uses a unique one-on-one …
LBG recently announced selection into the M2D2 IMPACT Cycle 4 accelerator program. IMPACT is a 12-week accelerator program that uses a unique one-on-one approach that connects startups with resources for commercialization, …
LBG team members Allen Duplantier, Ph.D., Darrel J. Rezac, Ph.D., Cassidy Cantin, and Amy Noon, Pharm.D., will join thought leaders and experts to discuss the latest ideas and innovations in …
